CCR5 is therefore overexpressed in breast, head, neck, gastric, esophageal, pancreatic and prostate cancer, colorectal carcinoma, melanoma, Hodgkin’s lymphoma, acute lymphocytic leukemia and other tumors [31]. Here, CCR5 is linked to melanoma.